Emily Woodworth - 13 Feb 2026 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP, Global Controller and CAO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
13 Feb 2026
Net transactions value
-$94,832
Form type
4
Filing time
18 Feb 2026, 17:58:54 UTC
Previous filing
17 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Woodworth Emily SVP, Global Controller and CAO 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH /s/ Susan Thompson, Attorney-in-Fact 18 Feb 2026 0002013518

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +1,413 +149% $0.000000 2,364 13 Feb 2026 Direct F1
transaction BSX Common Stock Tax liability $51,564 -690 -29% $74.73 1,674 13 Feb 2026 Direct
transaction BSX Common Stock Options Exercise $0 +661 +39% $0.000000 2,335 14 Feb 2026 Direct F1
transaction BSX Common Stock Tax liability $22,120 -296 -13% $74.73 2,039 14 Feb 2026 Direct
transaction BSX Common Stock Options Exercise $0 +637 +31% $0.000000 2,676 16 Feb 2026 Direct F1
transaction BSX Common Stock Tax liability $21,149 -283 -11% $74.73 2,393 16 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -1,413 -25% $0.000000 4,239 13 Feb 2026 Common Stock 1,413 Direct F1, F2
transaction BSX Restricted Stock Units Options Exercise $0 -661 -50% $0.000000 661 14 Feb 2026 Common Stock 661 Direct F1, F3
transaction BSX Restricted Stock Units Options Exercise $0 -637 -100% $0.000000 0 16 Feb 2026 Common Stock 637 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.